"Insurance Claim Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.
| Descriptor ID |
D007345
|
| MeSH Number(s) |
N03.219.521.576.215
|
| Concept/Terms |
Insurance Claim Review- Insurance Claim Review
- Review, Insurance Claim
- Claims Review
- Claims Analysis
- Review, Claims
- Claims Reviews
- Reviews, Claims
- Claim Review, Insurance
- Claim Reviews, Insurance
- Insurance Claim Reviews
- Reviews, Insurance Claim
- Analysis, Claims
- Analyses, Claims
- Claims Analyses
Insurance Audit- Insurance Audit
- Audit, Insurance
- Audits, Insurance
- Insurance Audits
|
Below are MeSH descriptors whose meaning is more general than "Insurance Claim Review".
Below are MeSH descriptors whose meaning is more specific than "Insurance Claim Review".
This graph shows the total number of publications written about "Insurance Claim Review" by people in this website by year, and whether "Insurance Claim Review" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insurance Claim Review" by people in Profiles.
-
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data. J Manag Care Spec Pharm. 2021 May; 27(5):639-649.
-
Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration. Ophthalmology. 2021 02; 128(2):248-255.
-
Review of National Insurance Claims Gives Insight into the Use and Misuse of Allergen-Specific, In Vitro Diagnostic Tests. J Appl Lab Med. 2020 03 01; 5(2):417-419.
-
Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists. Pharmacoepidemiol Drug Saf. 2014 Nov; 23(11):1160-7.
-
Harnessing claims to improve detection of surgical site infections following hysterectomy and colorectal surgery. Infect Control Hosp Epidemiol. 2013 Dec; 34(12):1321-3.
-
Use of Medicare claims to identify US hospitals with a high rate of surgical site infection after hip arthroplasty. Infect Control Hosp Epidemiol. 2013 Jan; 34(1):31-9.
-
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
-
Estimating anesthesia time using the medicare claim: a validation study. Anesthesiology. 2011 Aug; 115(2):322-33.
-
Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project. Contraception. 2011 Apr; 83(4):340-5.
-
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost. 2010 Jun; 103(6):1203-9.